Results for Definium Therapeutics psychedelic candidate for major depressive disorder “exceeded expectations,” according to ...

Metabolic dysfunction-associated steatohepatitis (MASH), primary biliary cholangitis (PBC) and primary sclerosing cholangitis ...

People taking Definium Therapeutics' DT120 showed long-lasting reductions in their depression symptoms compared to a placebo, ...

Researchers at the University of Michigan have developed a mathematical model that reveals how our circadian rhythms can have dramatic impacts on how our bodies interact with medicines. This could ...

Over the last few years, the SARS-CoV-2 virus, responsible for COVID-19, has undergone significant changes, evolving from the original wild-type strains to the highly transmissible omicron variant. In ...

GLP-1 (glucagon-like peptide-1) drugs, represented by ‘Wegovy’ and ‘Mounjaro’, are evolving beyond mere obesity treatments to ...

An Insilico Medicine drug candidate spawned by the company’s artificial intelligence technology now has clinical data showing breathing improvement in patients who have a debilitating lung disorder.

Type 2 diabetes medications, such as sulfonylureas, have been a mainstay of treating the disease since they came on the market in the early 1950s. However, although they are one of the most common ...

June 16 (Reuters) - Edgewise Therapeutics shares fell nearly 10% on Tuesday after the efficacy of its experimental heart-disease drug in a mid-stage study fell short of investor expectations. The ...

A new method seeks specific molecules that can target desired tissues through the bloodstream and penetrate tissues by passing through cells. This innovation could help solve issues related to drug ...